Diadema Partners »

Inovio Pharmaceuticals shares owned by Diadema Partners

Quarter-by-quarter ownership of Inovio Pharmaceuticals (INO) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Inovio Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inovio Pharmaceuticals held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inovio Pharmaceuticals by Diadema Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 634k 1.74

More positions owned by Diadema Partners

Viking Therapeutics (VKTX)
Vertex Pharmaceuticals Incorporated (VRTX)
Bridgebio Pharma (BBIO)
Spdr Series Trust State Street Spd Put Option (XBI)
Praxis Precision Medicines I Com New Put Option (PRAX)
Johnson & Johnson (JNJ)
Avidity Biosciences Ord Call Option (RNA)
Capricor Therapeutics Com New (CAPR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Jazz Pharmaceuticals Shs Usd Call Option (JAZZ)
Terns Pharmaceuticals (TERN)
Apogee Therapeutics Call Option (APGE)
Structure Therapeutics Sponsored Ads Call Option (GPCR)
Regeneron Pharmaceuticals (REGN)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Diadema Partners

Top funds holding Inovio Pharmaceuticals

Adage Capital Partners GP
Vanguard Group
Henderson Group
Boxer Capital Management
Millennium Management
ADAR1 Capital Management
D. E. Shaw & Co
Geode Capital Management
Diadema Partners
BlackRock
Renaissance Technologies
GSA Capital Partners
Susquehanna International
Northern Trust
Two Sigma Investments

View all funds holding Inovio Pharmaceuticals